Outcomes and prognostic factors of first-line combination of immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) in TFE3 -rearranged renal cell carcinoma.
| Autor: | Zhao, Junjie, Tang, Yanfeng, Hu, Xu, Chen, Junru, Liu, Haoyang, Liu, Haolin, Liang, Jiayu, Zhang, Xingming, Zhao, Jinge, Shen, Pengfei, Liu, Zhenhua, Sun, Guangxi, Zeng, Hao |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p429-429, 140p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|